PMA

P250018: RefluxStop® Device and RefluxStop® Deployment Tool

FDA PMA · IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX · Implantica CE Reflux, Ltd.

Key facts

PMA number P250018
Trade name RefluxStop® Device and RefluxStop® Deployment Tool
Generic name IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Applicant Implantica CE Reflux , Ltd.
Product code LEI
Approval date Aug 20, 2026

At a glance

  • None Supplements
  • Aug 20, 2026 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals